InspireMD Inc
XBER:II2
InspireMD Inc
XBER:II2
Price:
5.843
EUR
-2.42%
Market Closed
Market Cap:
€47.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
Innocean Worldwide Inc
KRX:214320
|
KR |
|
Thesis Gold Inc
XTSX:TAU
|
CA |
|
T
|
Telenet Group Holding NV
XBER:T4I
|
BE |
|
PAVmed Inc
NASDAQ:PAVM
|
US |
|
Westport Fuel Systems Inc
TSX:WPRT
|
CA |
|
KT Corp
NYSE:KT
|
KR |
Balance Sheet
Balance Sheet Decomposition
InspireMD Inc
InspireMD Inc
Balance Sheet Decomposition is not available for
InspireMD Inc
InspireMD Inc
Balance Sheet
InspireMD Inc
InspireMD Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
18
|
6
|
3
|
8
|
4
|
9
|
6
|
13
|
12
|
5
|
10
|
19
|
|
| Cash Equivalents |
18
|
6
|
3
|
8
|
4
|
9
|
6
|
13
|
12
|
5
|
10
|
19
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
13
|
29
|
16
|
|
| Total Receivables |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Accounts Receivables |
2
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Inventory |
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
22
|
9
|
5
|
9
|
5
|
11
|
8
|
15
|
37
|
21
|
44
|
41
|
|
| PP&E Net |
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
5
|
|
| PP&E Gross |
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
5
|
|
| Accumulated Depreciation |
1
|
1
|
0
|
1
|
1
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
2
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Total Assets |
24
N/A
|
11
-52%
|
6
-50%
|
9
+65%
|
6
-35%
|
12
+101%
|
10
-20%
|
18
+80%
|
40
+123%
|
25
-38%
|
48
+93%
|
47
-2%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
2
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
3
|
4
|
2
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
5
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
4
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
6
|
8
|
7
|
5
|
2
|
3
|
3
|
4
|
4
|
5
|
6
|
8
|
|
| Long-Term Debt |
9
|
5
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
|
| Total Liabilities |
15
N/A
|
14
-7%
|
9
-39%
|
5
-38%
|
3
-42%
|
4
+14%
|
5
+27%
|
6
+25%
|
6
+10%
|
7
+17%
|
8
+12%
|
11
+32%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
82
|
107
|
123
|
132
|
140
|
148
|
158
|
168
|
183
|
202
|
222
|
254
|
|
| Additional Paid In Capital |
91
|
105
|
120
|
136
|
143
|
156
|
163
|
180
|
217
|
219
|
261
|
290
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
3
N/A
|
3
-6%
|
4
N/A
|
3
-26%
|
9
+192%
|
5
-39%
|
12
+126%
|
34
+176%
|
17
-48%
|
40
+127%
|
36
-9%
|
|
| Total Liabilities & Equity |
24
N/A
|
11
-52%
|
6
-50%
|
9
+65%
|
6
-35%
|
12
+101%
|
10
-20%
|
18
+80%
|
40
+123%
|
25
-38%
|
48
+93%
|
47
-2%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
8
|
8
|
22
|
27
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
